TY  - RPRT
TI  - Efficacy of the MEK1/2 inhibitor trametinib in combination with clinically-investigated γ-secretase inhibitors in rhabdomyosarcoma
AU  - Cleary, M.
AU  - Hawkins, D. S.
AU  - Keller, C.
PY  - 2019
DO  - 10.1101/622522
UR  - https://www.biorxiv.org/content/10.1101/622522v1
ID  - 10.1101/622522
ER  -